Cubist Systematic Strategies’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Cubist Systematic Strategies’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-406,840	Closed	-$4.1M	–	4784
2022 Q4	$4.1M	Buy	406,840 +101,676	+33%	+$1.01M	0.02%	1203
2022 Q3	$3.02M	Buy	305,164 +10,262	+3%	+$101K	0.02%	1589
2022 Q2	$2.88M	Buy	294,902 +14,131	+5%	+$138K	0.02%	1505
2022 Q1	$2.75M	Sell	280,771 -36	-0%	-$350	0.02%	1221
2021 Q4	$2.73M	Buy	+280,807	New	+$2.73M	0.03%	1105

Cubist Systematic Strategies's MSAC Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 406,840 shares — an estimated $4.1M sold.

Cubist Systematic Strategies first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $4.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Cubist Systematic Strategies reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 406,840 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $4.1M.
Cubist Systematic Strategies first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Cubist Systematic Strategies's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $4.1M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.